Latest Breaking News On - Oral presentation - Page 2 : comparemela.com

Mironid Presents Translational Data in Oral Presentation at the European Renal Association Congress

Mironid Presents Translational Data in Oral Presentation at the European Renal Association Congress 28 May 2024, Glasgow, Scotland – Mironid…

United kingdomGlasgow citySukaina virji lindsey nevilleAdele rowleyEuropean renal association congressEuropean renal associationMironid presents translational dataOral presentationAutosomal dominant polycystic kidney diseaseLindsey neville

Antengene To Present One Oral and Four Abstracts at ASCO 2024

/PRNewswire/ Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated.

United statesSouth koreaHong kongMccormick placeAsia pacificPeter qianAntengene corporation limitedPrnewswire antengene corporation limitedMccormick place convention centerHong kong stock exchangeCompany annualAntengene corporationAmerican society of clinical oncologyOral presentationCorporation limitedClinical oncology

Celltrion USA Announces Two-Year Data For ZYMFENTRATM(Infliximab-Dyyb) To Be Presented At Digestive Disease Week (DDW) 2024 Conference

Celltrion USA Announces Two-Year Data For ZYMFENTRATM(Infliximab-Dyyb) To Be Presented At Digestive Disease Week (DDW) 2024 Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesSarah amundsenNam leeAmerican society for gastrointestinal endoscopyPublic health service actSociety for surgery of the alimentary tractAmerican gastroenterological associationDigestive disease weekMedical directorCelltrion united statesOral presentationDisease weekAmerican associationLiver diseasesAmerican society

Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

/PRNewswire/ Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult.

United statesNew jerseyNam leeSarah amundsenAmerican society for gastrointestinal endoscopyPublic health service actSociety for surgery of the alimentary tractAmerican gastroenterological associationDigestive diseaseMedical directorCelltrion united statesOral presentationDigestive disease weekAmerican associationLiver diseasesAmerican society

AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K

a6269o FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

United kingdomUnited statesIskra reicGhady haidarAdrian kempMeerausw immunocompromiseHealth database studySecurities exchangeCompany on social media astrazenecaUniversity of pittsburgh medical centerLarge united states commercial insurance health planForum infect disInvestor relations teamCommission file numberCompany secretaryLancet regional health